NeoRhythm PEMF Vagus Nerve Stimulation: Product Description and Study Analysis

PEMF therapy is a non-invasive technology that uses electromagnetic fields to support the body’s natural processes.

The NeoRhythm device, developed by Omnipemf, is designed to stimulate the vagus nerve via the neck, a nerve that plays a central role in the autonomic nervous system and regulates functions such as heart rate and relaxation. The study, conducted between March 25, 2023 and January 10, 2024, investigated the effect of three frequencies – 6 Hz, 16 Hz and 32 Hz – compared with a placebo group, using the NeoRhythm U-band. The results showed that the 16 Hz frequency produced significant improvements in sleep quality and general well-being, while 32 Hz was most effective for stress reduction. The report describes the device’s technical details, methods of use and potential benefits based on these findings, and provides a balanced presentation without suggesting treatment of specific diseases. Additional details from Omnipemf include a 60-day risk-free trial period, user satisfaction surveys and an active Facebook group with more than 10,500 members.

Benefits and effects
NeoRhythm may help reduce stress and worry through stimulation of the vagus nerve, which is known to influence the parasympathetic nervous system and promote calm. The study showed that the 32 Hz group achieved an average stress reduction of 23 points on the VAS scale after one month, while both 16 Hz and 32 Hz reduced worry by 15 points. Omnipemf confirms that 32 Hz is most effective for stress reduction, while both frequencies are equally effective against worry, with positive effects still visible one week after use. These effects may support daily well-being and help users manage busy lifestyles.

Users have also reported increased energy and focus. One customer in a review from February 19, 2025 mentioned that NeoRhythm helped with focus and relaxation after work, while another (February 2, 2025) experienced falling asleep faster and better sleep quality, which eliminated the need for supplements such as melatonin. Omnipemf highlights that regular use may improve vagal tone, which is linked to better overall well-being, and offers "Quick Start Programs" for vagus nerve stimulation that integrate seamlessly into daily life.

The device is non-invasive and easy to use, making it accessible to individuals who want to integrate technology into their daily routine without complicated procedures. It requires no surgical interventions, unlike traditional vagus nerve stimulation methods, and has a favorable safety profile with few reported side effects. Omnipemf also offers a 60-day risk-free trial period with easy returns, giving users confidence to test the device. This, combined with positive feedback from a Facebook group with more than 10,500 members and weekly Q&A sessions with Dr. Igor Jerman, makes NeoRhythm an attractive option for those seeking non-pharmacological solutions to support their overall health.

Technical specifications
The NeoRhythm device offers several potential benefits for general health and well-being, based on study results, user reports, and Omnipemf’s descriptions. The device may help improve sleep quality by supporting the body’s natural relaxation processes. In the study, the 16 Hz group reported an average increase in sleep quality of up to 15 points on the Visual Analogue Scale (VAS) after 30 days of use, indicating a very good effect on rest and recovery. This is supported by Omnipemf’s website, which highlights that 16 Hz achieved the highest score in sleep improvement, especially on day 6, when the greatest number of participants reported positive changes. This may be particularly useful for individuals who experience sleep disturbances or want deeper sleep without the use of medication.

NeoRhythm U-band is a portable device designed to deliver PEMF stimulation directly to the neck, targeting the vagus nerve. Here is a detailed overview of its technical features, based on the study and Omnipemf’s resources:

• Frequency selection: The device offers three main frequencies – 6 Hz, 16 Hz, and 32 Hz – which were tested in the study. 16 Hz is recommended for sleep and general well-being, while 32 Hz is most effective for stress reduction, as confirmed by Omnipemf.

• Magnetic intensity: Peak intensity of 2.5 millitesla (mT), which is within safe limits for PEMF therapy and sufficient to affect nerve tissue without direct contact with the skin.

• Power source: Rechargeable battery via USB-micro (some users, such as in a review from January 3, 2025, have requested USB-C for easier charging), with a battery life that supports multiple sessions per charge. Users report that it lasts for several days, as mentioned on January 4, 2025.

• Design: An ergonomic U-shaped band that is placed comfortably around the neck. It is lightweight and suitable for daily use, with a weight that users describe as ideal for neck placement (January 5, 2025). NeoRhythm Pad is a smaller variant for use on other parts of the body.

• Control: Controlled via a mobile app, which allows users to select frequencies and customize programs. The app includes preset modes for sleep, relaxation, and focus, as well as an advanced mode for custom sequences, as praised in a review from January 6, 2025.

• Usage time: The study recommended 30 minutes daily, but the guidelines suggest use once or twice per day depending on need. The Omnipemf FAQ suggests flexible use without a specific upper limit, but recommends hydration before and after sessions.

• Materials: Made from durable, skin-friendly materials, although exact specifications have not been publicly disclosed. The package includes a charging cable, reset tool, and a magnetic tube for testing.

Uno Vita AS offers three design variants of NeoRhythm with the same technical functions, but adapted to different lifestyles: the U-band for neck use, the pad for targeted use, and a third variant (not specified in detail).

Comprehensive and detailed description

PEMF therapy has a long history dating back to the 19th century, when early researchers such as James L. Corning experimented with electromagnetic fields to influence the nervous system. Modern research has shown that PEMF may support cellular functions, blood flow, and nerve activity, making it a promising field within wellness and biohacking. NeoRhythm builds on this legacy by targeting the vagus nerve, which connects the brain to many internal organs and influences parasympathetic responses such as relaxation and recovery. Omnipemf describes how the device sends targeted pulses that affect the electrical signals of the vagus nerve, which may strengthen its regulation of mood, digestion, and immune response.

The study, which began on 25 March 2023 and ended on 10 January 2024, is one of the largest of its kind, with an initial group of 485 volunteers, although the analyses were based on 446 respondents who completed at least one follow-up measurement. The participants varied in age (19.8% between 21-40 years, 50.9% between 41-60 years, 29.5% over 60 years) and employment status (44.5% employed, 23.9% self-employed, 19.3% retired). Approximately half reported existing health challenges, and two-thirds used medications or supplements, providing a broad basis for assessing the device's effects. Prof. Dr. Igor Jerman, director of the Bion Institute, emphasizes that this is the largest global study of PEMF on the vagus nerve, with significant improvements in sleep, relaxation, and symptoms of worry.

NeoRhythm was used in a double-blind, placebo-controlled study in which participants did not know whether they were receiving active stimulation (6 Hz, 16 Hz, 32 Hz) or placebo (0 Hz). Measurements were taken via questionnaires over five weeks, including an introductory survey, ongoing surveys (day 3, 6, 11, 16, 23, 30), and a follow-up seven days after completion. The VAS scale (0-100) was used to assess parameters such as sleep quality, general well-being, stress, and worry.

The results showed clear differences between the frequencies. 16 Hz produced the greatest improvement in general well-being (9-point average increase after 30 days) and sleep quality (15 points), especially among those with initially low well-being (VAS ≤ 50), where the increase was up to 15 points. Omnipemf confirms that 16 Hz had the strongest effect on day 6 for sleep improvement. 32 Hz was most effective for stress reduction (23 points) and also reduced worry (15 points), while 6 Hz showed minimal effects and was combined with the placebo group in the analysis. The placebo group experienced moderate improvements (5 points in sleep, 11 points in worry), which may be attributed to daily relaxation alone. Long-term effects were observed seven days after completion, with the 16 Hz group maintaining the well-being level from day 30, while reductions in stress and worry began to decline in all groups, although relative differences compared with placebo persisted. This is supported by Omnipemf, which claims that positive effects may last for a week after use, indicating a lasting impact on the nervous system.
Users have reported similar experiences. A review from 14 January 2025 mentioned improved sleep patterns measured with Fitbit and Withings, while another (13 January 2025) noted pain relief for bursitis and muscle problems when using the NeoRhythm Pad. One customer (3 January 2025) experienced that the device eliminated the need for sleeping medication after several months of use, indicating a potential "retraining" of the brain to relax naturally. Omnipemf's monthly customer satisfaction surveys (scale 1-10) provide further insight into user experiences, and their Facebook group with more than 10,500 members offers a community for discussion and support, including weekly Q&A sessions with Dr. Jerman.

NeoRhythm can be used in several ways:

• Sleep improvement: Place the U-band around the neck or use the pad under the pillow at 16 Hz for 30 minutes before bedtime, as recommended in the study and Omnipemf’s guidelines.

• Stress reduction: Use 32 Hz in 30-minute sessions, once or twice daily, as shown to be most effective in the study and confirmed by Omnipemf.

• Focus and energy: Select preset modes via the app to support mental states during work or meditation, as reported by an experienced meditator (January 12, 2025).

• Pain relief: Place the pad on specific areas such as the hips or back, as shown in reviews from January 4 and 7, 2025, where users experienced relief from rib pain and neck arthritis.

To maximize the effect, regular use for at least two weeks is recommended. If the effect decreases, the guidelines suggest a 3–4 day break before continuing. The device requires minimal maintenance – store it dry and clean, and charge the battery when necessary. 

Disclaimer and reservations
Use of NeoRhythm should take place in consultation with qualified healthcare professionals, especially for individuals with medical conditions such as heart disease or implants such as pacemakers. The device must be kept out of reach of children. Uno Vita AS and Omnipemf do not claim that the product can diagnose, treat, cure, or prevent any disease. Results may vary between individuals, and use is intended as a supplement to general health and well-being, not as a substitute for medical treatment. NeoRhythm has not been evaluated by the FDA, and users are encouraged to consult a physician if they have health concerns. The Omnipemf FAQ confirms that the device is safe when used correctly, with a recommendation for hydration to avoid minor side effects.

Freedom of expression and the right to information
Uno Vita and Omnipemf reserve the right to share publicly available research on PEMF therapy and vagus nerve stimulation in accordance with the UN Universal Declaration of Human Rights (1948), Article 19, the International Covenant on Civil and Political Rights (1966), Article 19, Section 100 of the Norwegian Constitution, and the First Amendment of the United States. This ensures the freedom to seek, receive, and impart information about health and wellness technologies without government interference, in support of users’ right to knowledge.

References

• Jerman, I., Škafar, M., Pihir, J., & Senica, M. (2025). Evaluating PEMF vagus nerve stimulation through neck application: A randomized placebo study with volunteers. Electromagnetic Biology and Medicine. https://doi.org/10.1080/15368378.2025.2462649

• Binboğa, E., Tok, S., & Munzuroğlu, M. (2021). The short-term effect of occupational levels of 50 Hz electromagnetic field on human heart rate variability. Bioelectromagnetics, 42(1), 60-75. https://doi.org/10.1002/bem.22308

• Bremner, J. D., et al. (2020). Application of noninvasive vagal nerve stimulation to stress-related psychiatric disorders. Journal of Personalized Medicine , 10(3), E119. https://doi.org/10.3390/jpm10030119

• Ferstl, M., et al. (2021). Non-invasive vagus nerve stimulation boosts mood recovery after exertion. Psychological Medicine, 1-11. https://doi.org/10.1017/S0033291720005073

• Greco, A., & Garoli, A. (2019). Effects of non-focused ELF-EMF treatment on EEG: Preliminary study. Translational Neuroscience Research and Reviews, 2(1), 38-52. https://doi.org/10.36959/817/524

• Grote, V., et al. (2007). Short-term effects of pulsed electromagnetic fields after physical exercise depend on autonomic tone before exposure. European Journal of Applied Physiology, 101(4), 495-502. https://doi.org/10.1007/s00421-007-0520-x

• Machetanz, K., et al. (2021). Transcutaneous auricular vagus nerve stimulation and heart rate variability: Analysis of parameters and targets. Autonomic Neuroscience, 236, 102894. https://doi.org/10.1016/j.autneu.2021.102894

• Mouli, S., et al. (2021). Tragus-based vagus nerve stimulation for stress reduction. Proceedings of the 14th International Joint Conference on Biomedical Engineering Systems and Technologies, 164-168. https://doi.org/10.5220/0010222201640168

• Park, S. J., et al. (2019). Physiological evaluation of a non-invasive wearable vagus nerve stimulation (VNS) device. International Conference on Applied Human Factors and Ergonomics, 57-62. Springer.

• Möbius, H., & Welkoborsky, H. J. (2022). Vagus nerve stimulation for conservative therapy-refractory epilepsy and depression. Laryngo-Rhino-Otologie, 101, S114-S143. https://doi.org/10.1055/a-1660-5591

• Johnson, R. L., & Wilson, C. G. (2018). A review of vagus nerve stimulation as a therapeutic intervention. Journal of Inflammation Research, 11, 203-213. https://doi.org/10.2147/JIR.S163248

• Pelka, R. B., Jaenicke, C., & Gruenwald, J. (2001). Impulse magnetic-field therapy for insomnia: A double-blind, placebo-controlled study. Advances in Therapy, 18(4), 174-180. https://doi.org/10.1007/BF02850111